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Typically, the lesion is accessed via the transfemoral route,
and insertion of sheaths is a routine component of these
procedures. Moderate or large hematomas have been repor-
ted in up to 4% of hospitalized patients after femoral cath-
eterization [1], and, therefore, postprocedure removal of
these sheaths still poses risks as well as time constraints on
the physician.
It is remarkable that almost a half century since the
introduction of the Seldinger technique, manual compression
still remains the criterion standard for achieving hemostasis
after gaining vascular access for diagnostic and interven-
tional arterial catheterization. Increasing time pressure,
issues of patient satisfaction, and the use of large-diameter
catheters for endovascular intervention, however, have
recently necessitated alternative ways of establishing poste
endovascular procedure hemostasis.
Since the early 1990s, various devices have been used to
achieve hemostasis after arterial puncture. These hemostatic
devices can be categorized into 3 main types according to
their mechanism of action: pressure devices (CompressAR
System; Femostop; RADI Medical Systems, Wilmington,
MA), topical hemostatic pads, and vascular closure devices.* Address for correspondence: Arul Ganeshan, MBBCH, BSc, MRCP,
FRCR, Department of Radiology, The Heartlands NHS Foundation Trust,
Bordesely Green East, Birmingham B9 5SS, United Kingdom.
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doi:10.1016/j.carj.2010.02.005The method of achieving hemostasis after arterial catheteri-
zation currently varies among and within institutions, and
there is currently no best practice recommendation for this.
The CompressAR System was the first mechanical
compression device ever to replace manual compression for
postcatheterization femoral hemostasis. A newer version of
the CompressAR System, the CompressAR StrongArm
(UK Medical, Sheffield, United Kingdom), was introduced in
2002. The CompressAR StrongArm is a similar C-clamp
compression device to its predecessor, which comprises
a nondisposable stand (Figure 1) on which a single dispos-
able sterile disc is used to provide vascular compression for
purposes of achieving femoral hemostasis. This latest version
has a more durable connection to the arm for reliable femoral
compression; a ‘‘sure-grip’’ elastomeric material on the
undersurface to increase patient comfort and reduce chance
of distal disc migration; and a ‘‘V-shaped notch’’ on the
sterile disc (Figure 2), which enables proper visualization
and facilitates cleaning of the puncture site.
In this article, we report the findings of the first
prospective audit aimed at evaluating the use of the Com-
pressAR StrongArm mechanical compression device in
establishing hemostasis after transfemoral angioplasty in the
interventional radiology day-case setting.Methods
The audit sample consisted of 81 consecutive adult
patients undergoing elective day-case lower limb angioplastyll rights reserved.
Figure 1. CompressAR StrongArm stand.
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CompressAR StrongArm device was used to provide
mechanical compression for hemostasis in 84 puncture sites
in these patients. Staff at the interventional day-case unit had
formal in-house training on the procedure for applying the
clamp. Representatives from the manufacturer were respon-
sible for assessing and maintaining staff competence in the
use of the compression device.
Informed patient consent was obtained by the attending
interventional radiologist before the catheterizationFigure 2. CompressAR StrongArm ‘‘supercomfort’’ discs are made of a new
sure-grip elastomeric material, which reportedly provides more stable disc
positioning for a secure compression. The V-notch helps clinicians to aid
accurate placement of the disc on the patient, keep the puncture site clear of
blood, and observe the puncture site during compression release.procedure for the procedure itself and for the audit. In line
with our institutional policy with regard to audits of estab-
lished practice, approval for this study was obtained from the
Radiology Departmental Audit Committee. In all patients,
the time taken from subcutaneous administration of local
anaesthetic (lidocaine 1%) to successful needle cannulation
of the femoral artery was less than 5 minutes. All patients
were catheterized with 4F-6F vascular sheaths. All patients
received 3000 IU intra-arterial heparin during their elective
procedure.
A standard procedure was developed for application of the
device to ensure uniformity of use. To decrease variability in
sheath removal, the radiologist carrying out the vascular
intervention removed the sheaths and deployed the device.
The base of the clamp was positioned between the mattress
and the base of the patient’s bed. The arm was moved into
position in relation to the puncture site by rotation of the
shaft. The CompressAR disc was attached to a movable slide
on the horizontal support arm of the stand. This was then
lowered onto the femoral artery immediately proximal and
medial to the puncture site, with the sheath located in the
V-notch of the disc. The sheath was withdrawn as downward
pressure was simultaneously applied to the site. The hori-
zontal support arm was adjusted to exert firm pressure until
there was no further visible bleeding at the site, without
causing a visible hematoma or compromising distal arterial
blood flow. Firm pressure was applied for an initial period
(manufacturer recommendation of 5 or 6 minutes), depend-
ing on the size of the patient and the sheath size used.
Pressure was applied until the bleeding stopped and the disc
was seen to indent the skin around the puncture site. Once
adequate pressure was achieved, the device was locked in
place and released in a stepwise fashion by using a ratchet
mechanism at the appropriate time. The amount of pressure
applied had a subjective element, just as with hand
compression. After deployment, specialist nurses were
charged with monitoring the vascular access site and grad-
ually releasing compression until hemostasis was achieved.
If, after complete release, there was continued bleeding, the
nurse notified the radiologist, and the device was redeployed
in accordance with manufacturer’s recommendations.
The patients were monitored in a dedicated recovery area
within the radiology department. The specialist nurse
remained at the patient’s bedside for the entire duration of
the procedure. All patients received postprocedural instruc-
tions from the radiologist who had removed the sheath and
also from the nurse. Groin sites were inspected by the
nursing staff at the time of sheath removal, at 1 hour, and at 4
hours after the procedure. The groin site was also inspected
by the attending radiologist after 4 hours and before
discharge. Complications were noted in the form of groin
hematoma, continuing bleeding from the puncture site,
hypotension (defined as a fall in the systolic blood pressure
of 20 mm Hg from the preprocedure blood pressure
measurement), the need for intravenous fluids, and the
requirement for surgery for incessant bleeding. If a groin
complication developed, then the nursing personnel notified
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followed up at 24 hours after the procedure by telephone
interview by the nurse who had attended the patient. The
questions specifically addressed pain scores, whether there
had been bleeding after discharge, and whether there was
swelling or bruising at the puncture site. Pain was scored
according to a standard scale, which ranged from 0 (no pain)
to 10 (severe pain). All data were entered onto a pre-
determined questionnaire. Data were analysed by using
frequency distributions and measures of central tendency.
ResultsDeployment of DeviceThe device was used to achieve hemostasis at 84 femoral
arterial puncture sites in 81 patients. The main results related
to their hospital stay in the radiology recovery area are shownTable 1
Results from deployment of the device relating to the first 4 hours after
sheath removal
N 81 patients; 84 procedures
Age, y
Mean (SD) 69.3  1.3
Range 42e94
Puncture approach
Antegrade 56 (66.7%)
Retrograde 28 (33.3%)
Sheath size
4F 3 (3.5%)
5F 57 (67.9%)
6F 24 (28.5%)
Presheath removal hematoma
Yes 8 (9.5%)
No 76 (90.5%)
Device deployment time (min)
Mean (SD) 1.14  0.08
Range 0.33e3
Total time to hemostasis (min):
Mean (SD) 14.18  0.45
Range 7e35
Redeployment required?
Yes 16 (19%)
No 68 (81%)
Hematoma at 1 h?
Yes 20 (23.8%)
No 64 (76.2%)
Hematoma at 4 h?
Yes 9 (10.7%)
No 75 (89.3%)
Hypotensive?
Yes 45 (55.6%)
No 36 (44.4%)
Intravenous fluids?
Yes 10 (14.1%)
No 71 (85.9%)
Computed tomography angiogram?
Yes 1 (1.2%)
No 80 (98.8%)
Admission and/or surgery?
Yes 1 (1.2%)
No 80 (98.8%)in Table 1. From the figures, it can be deduced that the device
was easy to deploy, with a total mean deployment time
(including those cases in which it had to be reapplied) of just
over 1 minute. Hemostasis was immediate and complete at 68
puncture sites (81%) after the first deployment. In 16 cases
(19%), the device had to be reapplied because of inadequate
hemostasis. In 5 patients (6%), the device had to be redeployed
for the second time. Initial hemostasis was achieved in all 81
patients, with a mean total deployment time of 14.2 minutes.
This included the time to initially deploy the device, the initial
compression, and, finally, the time taken to fully release the
pressure. It is important to note that, although in 9 patients
there was a hematoma noted at discharge, in 8 of these cases, it
was present before clamp deployment.Complications Related to CompressAR StrongArm
DeviceHematoma at 1 hour was seen in 20 patients and in only 9
patients at 4 hours. These were all minor hematomas (ie,
<5 cm) that dissipated during the patient’s recovery. Forty-
five patients were hypotensive at some point in the first 4
hours after the procedure, but only 10 patients were admin-
istered intravenous fluids. Of these, 4 were administered
intravenous fluids as a precaution because of pre-existing
renal failure. The remaining 6 patients were given fluids
because of sustained hypotension (15 minutes). In 5 of
these patients, it was thought that this was probably because
of a vasovagal response rather than a true reduction in venous
return, because both bleeding and the presence of a false
aneurysm were excluded by bed-side ultrasound examina-
tion. Only 1 patient required further imaging in the form of
computed tomographic (CT) angiography because of
continued ooze from the puncture site at 4 hours. In this case,
there was no identifiable cause for the failure of the
compression device because the procedure was straightfor-
ward. The patient had an enlarging hematoma and reduced
blood pressure after the procedure. Subsequent CT angiog-
raphy showed some active bleeding, which was managed
conservatively. The patient was discharged home on the
following day. No patient required further intervention in the
form of transfusion or surgical repair.
The findings of the telephone interview undertaken at 24
hours are displayed in Table 2. All discharged patients stated
that they were comfortable at this time. No discharged
patient experienced a rebleed from the puncture site or major
hematoma within the first 24 hours.
All 10 patients who reported groin swelling the day after
the procedure stated that these were small (<3 cm). These
included the 9 patients who reported a hematoma within 24
hours of discharge (after leaving the hospital). The incidence
of risk factors predisposing to bleeding in this patient group
(obesity, hypertension, repeated puncture, vessel calcifica-
tion, and long intake of anti-aggregation drugs) are shown in
Table 3. All patients were followed up at 6 months via
a telephone call, and none were readmitted as a consequence
of groin-related complications.
Table 2
Results obtained at 24 hours after the procedure via telephone interview
No. patients (%)
Comfortable at 24 h?
Yes 81 (100)
No 0 (0)
Swelling at 24 h?
Yes 10 (11.9)
No 74 (88.1)
Small 10 (100)
Large 0 (0)
Bruising at 24 h?
Yes 27 (32.1)
No 57 (67.9)
Bleeding within
the first 24 h?
Yes 1 (1.2)
No 83 (98.8)
Table 4
Pain scoring data assessed at the time of deployment up to 24 hours after the
procedure
Pain score after deployment
Mean (SD) 2.18  0.24
Range 0e8
Pain score at 1 h
Mean (SD) 0.50  0.14
Range 0e6
Pain score at 4 h
Mean (SD) 0.29  0.09
Range 0e5
Pain score at 24 h
Mean (SD) 0.98  0.17
Range 0e6
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and 24 hours are shown in Table 4. The individual pain
scores at 24 hours are shown in Figure 3. Most patients
reported no pain at all.Discussion
Sheath removal is a routine part of nursing and physician
practice after transfemoral catheterization and angioplasty.
Although a recent North American survey noted that, in two-
thirds of hospitals, nurses removed sheaths without physician
supervision [2], at our institution, this is currently a time-
consuming process undertaken by the attending vascular
interventionist.
The traditional method for sheath removal is manual
compression on the puncture site, but this has gradually
changed over time, with the development of various
mechanical and invasive methods applied to the arteriotomy
site. It was found that, in 39% of the hospitals surveyed in
a North American study, pressure devices were being used
‘‘frequently’’ to achieve hemostasis after arterial punctures
[2].Table 3
Results obtained at 24 hours after the procedure via telephone interview
Patient no. Risk factors for bleeding
1 Hypertension, obesity,
repeated puncture
2 Aspirin, hypertension
3 None
4 None
5 Obesity, hypertension, aspirin
6 Aspirin
7 Obesity, hypertension
8 None
9 None
10 NoneSeveral studies have shown support for the use of the
earlier standard CompressAR device after sheath removal in
femoral punctures. A large multicentre study that compared
manual compression with the CompressAR to achieve
hemostasis, found that mechanical compression by using the
CompressAR was less time consuming and was associated
with a lower incidence of hematoma [3]. Other investigators
concluded that the CompressAR was equally effective to
manual compression but was more time consuming [4,5]. A
recent meta-analysis on the effectiveness of mechanical
compression devices in attaining hemostasis after femoral
sheath removal indicates that mechanical pressure is more
effective than manual compression in preventing hematoma
formation [6].
There are currently no data assessing the CompressAR
StrongArm device in day-case patients undergoing trans-
femoral peripheral angioplasty procedures. In this audit, the
use of the system was associated with low access-site
complication rates and ensured safe postcatheterization
femoral hemostasis. Effective hemostasis was achieved in 80
of 81 patients (99%), with only 1 requiring further imaging
for bleeding (CT angiogram) and subsequent admission. No
patients required surgery.
At first glance, the hematoma rate at 24 hours of 11.9%
appears high but it must be borne in mind that, of these, 9Figure 3. Individual pain scores at 24 hours.
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risk factors are known to influence the incidence of post-
compression complications (Table 3). It is clear from the data
that the incidence of these factors cannot be said to have
influenced the compression outcome. Only half of the 10
patients who reported hematoma at 24 hours reported at least
1 of these risk factors. The other 5 reported no such risk
factors.
Pseudoaneurysm is a serious vascular complication that is
usually difficult to recognize, especially in the presence of
a hematoma [7]. It was previously suggested that the prev-
alence of pseudoaneurysm formation is significantly higher
when manual compression is used to ensure hemostasis [8].
Although clearly our audit is not a randomized study, none of
the patients in the sample developed a subsequent pseudoa-
neurysm. There are no conclusive randomized trials that
compared the rates of arteriovenous fistula formation or
incidence local venous or arterial thromboses between
mechanical pressure devices and manual compression. We
report that none of these complications were seen in our
treatment group.
Pain scores reported by patients were low, and so hemo-
static efficacy was not at the detriment of patient comfort.
With regard to a comparison in patient comfort between the
use of the CompressAR StrongArm and manual compres-
sion, we have anecdotal evidence from 3 patients in our
series who, on a previous occasion, had manual compression
after angioplasty. They all stated that they preferred the
CompressAR, but we have no direct comparison.
Another advantage was that the use of the device elimi-
nated the need for manually compressing the femoral artery
and allowed hands-free mechanical compression. This not
only minimized exposure to blood during the hemostasis
period but also increased nurse and physician productivity.
The fact that our nursing staff had their ‘‘hands free’’ allowed
them to chart observations and give medications. It is
convention for the intervening radiologist to apply manual
pressure after the procedure. The use of the CompressAR
device placed the responsibility of monitoring the puncture
site with the nursing staff once the device was used, and, in
practical terms, this undoubtedly provided a time advantage
over the traditional manual compression method.
Utilisation of the CompressAR StrongArm allowed
hemostasis to be achieved with a minimum of effort and
without the variable pressure that is unavoidable when the
pressure is by hand. There is a tendency to ‘‘peek’’ when using
one’s hands to maintain pressure to see if hemostasis has
occurred, which can predispose to hematoma formation [3].
Because staff avoid having to use manual compression, the
risks of injury caused by repetitive motion are reduced. As well
as its repetitive nature, manual compression is associated with
the requirement of significant force, poor posture, severe hand
fatigue, tendonitis, and carpal tunnel syndrome [9].
We believe that this device offers advantages over older
compression devices. For example, the Femostop relies on
hydraulic pressure exceeding systemic pressure, so that, as
the patient’s blood pressure comes down, it exerts a higherpressure against the arterial wall. This can lead to arterial
thrombosis and ischemia of the lower extremity. There have
been reported iliac femoral grafts closing because of this
complication. This has not yet been associated with use of
the CompressAR.
The use of vascular closure devices certainly seems to
have taken off over the last few years. However, in terms of
hemostasis, the benefit of these devices over manual
compression methods is contentious, and several investiga-
tors cited the lack of randomized long-term clinical trials in
demonstrating a clear advantage for the use of vascular
closure devices [10]. In fact, recent commentators concluded
that, after cardiac catheterization, there is no advantage in
using vascular closure devices, because early ambulation can
be achieved with manual compression methods, which are
inherently more economical [11]. Vascular closure devices
are relatively expensive and are more than 20% of the cost of
the CompressAR, with the only consumable cost being the
disc. In addition, in a systematic review and meta-analysis of
30 trials that compared arterial puncture closing devices with
standard manual compression after cardiac catheterization,
Koreny et al [12] found that there is only marginal evidence
that closure devices are effective, and they express concern
that these devices may increase the risk of hematoma and
pseudoaneurysm.
Infection, embolic, and vascular thrombotic complications
associated with the use of vascular closure devices to achieve
femoral hemostasis are uncommon but are serious compli-
cations associated with a high morbidity, which necessitates
a need for aggressive intervention to salvage the situation
[13]. These risks can also be minimized with mechanical
compression.
Based on the results of this small study, it appears that the
CompressAR StrongArm is an ideal hemostatic device in
patients undergoing day-case interventional procedures and
offers a low level of patient discomfort. It is user friendly,
simple, and inexpensive, and provides rapid, reliable hemo-
stasis. It is safe and likely to become a suitable alternative to
other more-invasive closure devices.
Limitations of this audit include its small sample size and
the fact that this was not a randomized study. Randomized
controlled studies with larger sample populations that
compare different methods of achieving hemostasis (manual
compression, mechanical compression and closure device)
are needed to ensure a more accurate data set that can be
applied to the patient population.References
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